Investment Portfolio
-
100Doc Technology
100Doc Technology is a to-B-services company focusing on pharmaceutical marketing services, using products based on cloud service architecture and SaaS model to empower digital marketing transformation of pharmaceutical enterprises. With the SaaS model, 100Doc provides pharmaceutical companies with exclusive and privatized one-stop digital marketing platform.
-
Ruipeng Pet Veterinary Group
Ruipeng is the largest pet veterinary chain in Asia with over 1,000 stores covering major provinces and cities across the China. Ruipeng provides comprehensive one-stop pet services for pet owners through three major product lines: pet veterinary services, pet grooming, and pet food.
-
Huigene
Huigene is committed to development of new gene therapeutical technologies and drugs. It has established numerous core technology platforms including gene editing, viral vector technology, and animal model establishment and validation. Multiple pipelines have completed preclinical animal validation and are entering the stage of GMP-grade production and IND declaration.
-
R&G-Pharma
R&G-Pharma is an industry leader and one of the largest clinical contract research organizations (CRO) in China. The company provides comprehensive services, covering clinical trial technical data management and statistical analysis, biological sample testing, clinical pharmacology, etc.
-
Hamony Long
Hamony Long Dental maintains a strategic overall setup across the entire industrial chain of the dental industry, with medical services (4 dental hospitals and 20 dental clinics) as its core, it also operates denture processing plants, and dental medical training and distribution companies that provide services internally.
-
NanoMicro
Nano-Micro is devoted to developing world-leading technologies for the production of the highest quality and the widest selection of uniformly sized nano- and microspheres (microparticles). The company is capable of supplying monodisperse particles of almost any size ranging from 5 nanometers to 1000 microns of different materials, structures, and functionalities. Nano-Micro’s provide a broad spectrum of products including high performance chromatography media, solid phase extraction (SPE) sorbents, particle size standards, magnetic particles, LCD spacer, ACF conductive particles, and various other customized functional microsphere products.
-
ClinPlus
ClinPlus provides one-stop clinical trial solutions. The main business is clinical trial Site Management Services (SMO). From the start of the project to the closure of the site, it provides high-quality SMO management services throughout the project cycle.
-
PharmaResources
PharmaResources(Shanghai) Co., Ltd is mainly engaged in the research, development, production and sales of high-end chemical APIs and intermediates at the international forefront.
-
Bioscience
Bioscience Diagnostic Technology（Tianjing） Co., Ltd. is an integrated In-Vitro Diagnostics product solutions provider focusing on the R&D, production and sales of CLIA（Chemiluminescence analysis）systems and reagents.
- © 2024 Huimei Capital All Rights Reserved.
京公网安备 11010102004125号